Effect of dimerized thrombin fragment TP508 on acute myocardial ischemia reperfusion injury in hypercholesterolemic swine

Journal of Pharmacology and Experimental Therapeutics

Volumn 334, Issue 2, 2010, Pages 449-459

  Oyamada, Shizu ^a   Osipov, Robert ^a   Bianchi, Cesario ^a   Robich, Michael P ^a   Feng, Jun ^a   Liu, Yuhong ^a   Burgess, Thomas A ^a   Bell, Timothy M ^b   Sheller, Michael R ^b   Sellke, Frank W ^a  

^a BROWN UNIVERSITY   (United States)

^b Capstone Therapeutics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CRYSTALLIN; AMINO ACID; HEAT SHOCK PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; TP508 AMINO ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DIMERIZATION; DRUG EFFECT; ENDOTHELIUM; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HYPERCHOLESTEROLEMIA; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; SWINE;

ACUTE DISEASE; ANIMALS; APOPTOSIS; BLOOD GLUCOSE; CORONARY VESSELS; DIMERIZATION; DRUG STABILITY; ENDOTHELIUM, VASCULAR; HYPERCHOLESTEROLEMIA; LIPIDS; MICROVESSELS; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; PEPTIDE FRAGMENTS; SOLUTIONS; SWINE; THROMBIN; VENTRICULAR FUNCTION, LEFT;

EID: 77954900599     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.110.166348     Document Type: Article

References (37)

1. Arrigo AP, Simon S, Gibert B, Kretz-Remy C, Nivon M, Czekalla A, Guillet D, Moulin M, Diaz-Latoud C, and Vicart P (2007) Hsp27 (HspB1) and αB-crystallin (HspB5) as therapeutic targets. FEBS Lett 581:3665-3674.
2. Bagnéris C, Bateman OA, Naylor CE, Cronin N, Boelens WC, Keep NH, and Slingsby C (2009) Crystal structures of α-crystallin domain dimers of αB-crystallin and Hsp20. J Mol Biol 392:1242-1252.
3. Benn SC, Perrelet D, Kato AC, Scholz J, Decosterd I, Mannion RJ, Bakowska JC, and Woolf CJ (2002) Hsp27 up-regulation and phosphorylation is required for injured sensory and motor neuron survival. Neuron 36:45-56.
4. Carney DH, Mann R, Redin WR, Pernia SD, Berry D, Heggers JP, Hayward PG, Robson MC, Christie J, and Annable C (1992) Enhancement of incisional wound healing and neovascularization in normal rats by thrombin and synthetic thrombin receptor-activating peptides. J Clin Invest 89:1469-1477.
5. Carra S, Seguin SJ, Lambert H, and Landry J (2008) HspB8 chaperone activity toward poly(Q)-containing proteins depends on its association with Bag3, a stimulator of macroautophagy. J Biol Chem 283:1437-1444.
6. Concannon CG, Orrenius S, and Samali A (2001) Hsp27 inhibits cytochrome c-mediated caspase activation by sequestering both pro-caspase-3 and cytochrome c. Gene Expr 9:195-201. (Pubitemid 32606842)
7. Coughlin SR (2000) Thrombin signalling and protease-activated receptors. Nature 407:258-264.
8. Deng X, Xiao L, Lang W, Gao F, Ruvolo P, and May WS Jr (2001) Novel role for JNK as a stress-activated Bcl2 kinase. J Biol Chem 276:23681-23688.
9. Elrod JW, Calvert JW, Morrison J, Doeller JE, Kraus DW, Tao L, Jiao X, Scalia R, Kiss L, Szabo C, et al. (2007) Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc Natl Acad Sci USA 104:15560-15565.
10. Garrido C, Bruey JM, Fromentin A, Hammann A, Arrigo AP, and Solary E (1999) HSP27 inhibits cytochrome c-dependent activation of procaspase-9. FASEB J 13:2061-2070. (Pubitemid 29517636)
11. Garrido C, Mehlen P, Fromentin A, Hammann A, Assem M, Arrigo AP, and Chauffert B (1996) Inconstant association between 27-kDa heat shock protein (Hsp27) content and doxorubicin resistance in human colon cancer cells. The doxorubicin-protecting effect of Hsp27. Eur J Biochem 237:653-659. (Pubitemid 126443875)
12. Garrido C, Ottavi P, Fromentin A, Hammann A, Arrigo AP, Chauffert B, and Mehlen P (1997) HSP27 as a mediator of confluence-dependent resistance to cell death induced by anticancer drugs. Cancer Res 57:2661-2667. (Pubitemid 27283777)
13. Hein TW, Zhang C, Wang W, Chang CI, Thengchaisri N, and Kuo L (2003) Ischemia-reperfusion selectively impairs nitric oxide-mediated dilation in coronary arterioles: counteracting role of arginase. FASEB J 17:2328-2330.
14. Ito H, Tomooka T, Sakai N, Yu H, Higashino Y, Fujii K, Masuyama T, Kitabatake A, and Minamino T (1992) Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation 85:1699-1705.
15. Knight DR, Smith AH, Flynn DM, MacAndrew JT, Ellery SS, Kong JX, Marala RB, Wester RT, Guzman-Perez A, Hill RJ, et al. (2001) A novel sodium-hydrogen exchanger isoform-1 inhibitor, zoniporide, reduces ischemic myocardial injury in vitro and in vivo. J Pharmacol Exp Ther 297:254-259.
16. Mao YW, Liu JP, Xiang H, and Li DW (2004) Human αA- and αB-crystallins bind to Bax and Bcl-X(S) to sequester their translocation during staurosporine-induced apoptosis. Cell Death Differ 11:512-526.
17. Mehlen P, Kretz-Remy C, Préville X, and Arrigo AP (1996) Human hsp27, Drosophila hsp27, and human αB-crystallin expression-mediated increase in glutathione is essential for the protective activity of these proteins against TNFα-induced cell death. EMBO J 15:2695-2706.
18. Nicolosi AC, Strande JL, Hsu A, Fu X, Su J, Gross GJ, and Baker JE (2008) Gadolinium limits myocardial infarction in the rat: dose-response, temporal relations, and mechanisms. J Mol Cell Cardiol 44:345-351.
19. Niemann CU, Saeed M, Akbari H, Jacobsen W, Benet LZ, Christians U, and Serkova N (2002) Close association between the reduction in myocardial energy metabolism and infarct size: dose-response assessment of cyclosporine. J Pharmacol Exp Ther 302:1123-1128.
20. Osipov RM, Bianchi C, Clements RT, Feng J, Liu Y, Xu SH, Robich MP, Wagstaff J, and Sellke FW (2009a) Thrombin fragment (TP508) decreases myocardial infarction and apoptosis after ischemia reperfusion injury. Ann Thorac Surg 87:786-793.
21. Osipov RM, Robich MP, Feng J, Clements RT, Liu Y, Glazer HP, Wagstaff J, Bianchi C, and Sellke FW (2009b) Effect of thrombin fragment (TP508) on myocardial ischemia-reperfusion injury in hypercholesterolemic pigs. J Appl Physiol 106: 1993-2001.
22. Pandey P, Farber R, Nakazawa A, Kumar S, Bharti A, Nalin C, Weichselbaum R, Kufe D, and Kharbanda S (2000) Hsp27 functions as a negative regulator of cytochrome c-dependent activation of procaspase-3. Oncogene 19:1975-1981.
23. Paul C, Manero F, Gonin S, Kretz-Remy C, Virot S, and Arrigo AP (2002) Hsp27 as a negative regulator of cytochrome c release. Mol Cell Biol 22:816-834. (Pubitemid 34053061)
24. Prasad A, Stone GW, Aymong E, Zimetbaum PJ, McLaughlin M, Mehran R, Garcia E, Tcheng JE, Cox DA, Grines CL, et al. (2004) Impact of ST-segment resolution after primary angioplasty on outcomes after myocardial infarction in elderly patients: an analysis from the CADILLAC trial. Am Heart J 147:669-675. (Pubitemid 38900454)
25. Prasad A and Gersh BJ (2005) Management of microvascular dysfunction and reperfusion injury. Heart 91:1530-1532.
26. Ryaby JT, Sheller MR, Levine BP, Bramlet DG, Ladd AL, and Carney DH (2006) Thrombin peptide TP508 stimulates cellular events leading to angiogenesis, revascularization, and repair of dermal and musculoskeletal tissues. J Bone Joint Surg Am 88:132-139.
27. Samali A and Cotter TG (1996) Heat shock proteins increase resistance to apoptosis. Exp Cell Res 223:163-170.
28. Samali A, Robertson JD, Peterson E, Manero F, van Zeijl L, Paul C, Cotgreave IA, Arrigo AP, and Orrenius S (2001) Hsp27 protects mitochondria of thermotolerant cells against apoptotic stimuli. Cell Stress Chaperones 6:49-58.
29. Sheller MR, Crowther RS, Kinney JH, Yang J, Di Jorio S, Breunig T, Carney DH, and Ryaby JT (2004) Repair of rabbit segmental defects with the thrombin peptide, TP508. J Orthop Res 22:1094-1099.
30. Sodha NR, Clements RT, Feng J, Liu Y, Bianchi C, Horvath EM, Szabo C, Stahl GL, and Sellke FW (2009) Hydrogen sulfide therapy attenuates the inflammatory response in a porcine model of myocardial ischemia/reperfusion injury. J Thorac Cardiovasc Surg 138:977-984.
31. Spurlock ME and Gabler NK (2008) The development of porcine models of obesity and the metabolic syndrome. J Nutr 138:397-402.
32. Stegh AH, Kesari S, Mahoney JE, Jenq HT, Forloney KL, Protopopov A, Louis DN, Chin L, and DePinho RA (2008) Bcl2L12-mediated inhibition of effector caspase-3 and caspase-7 via distinct mechanisms in glioblastoma. Proc Natl Acad Sci USA 105:10703-10708.
33. Stetler RA, Gao Y, Signore AP, Cao G, and Chen J (2009) HSP27: mechanisms of cellular protection against neuronal injury. Curr Mol Med 9:863-872.
34. Stiernberg J, Norfleet AM, Redin WR, Warner WS, Fritz RR, and Carney DH (2000) Acceleration of full-thickness wound healing in normal rats by the synthetic thrombin peptide, TP508. Wound Repair Regen 8:204-215.
35. Taylor RP and Benjamin IJ (2005) Small heat shock proteins: a new classification scheme in mammals. J Mol Cell Cardiol 38:433-444.
36. Wang H, Li X, Tomin E, Doty SB, Lane JM, Carney DH, and Ryaby JT (2005) Thrombin peptide (TP508) promotes fracture repair by up-regulating inflammatory mediators, early growth factors, and increasing angiogenesis. J Orthop Res 23:671-679.
37. Zuo L, Chen YR, Reyes LA, Lee HL, Chen CL, Villamena FA, and Zweier JL (2009) The radical trap 5,5-dimethyl-1-pyrroline N-oxide exerts dose-dependent protection against myocardial ischemia-reperfusion injury through preservation of mitochondrial electron transport. J Pharmacol Exp Ther 329:515-523.